Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Dubinsky

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Gastro Hep Advances|June 8, 2026
Efficacy of Upadacitinib Retreatment or Dose Escalation After Loss of Response in Ulcerative Colitis: Data From the Open-Label Extension of the U-ACTIVATE StudyRemo Panaccione, Jean-Frédéric Colombel, Marla Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 28, 2008
Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologistsBrennan M R Spiegel, Wayne Ho, Eric Esrailian, et al.
The Lancet. Gastroenterology & Hepatology|November 21, 2025
Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trialJess L Kaplan, Athos Bousvaros, Dan Turner, et al.
Digestive Diseases and Sciences|February 25, 2026
Epidemiology and Treatment of Inflammatory Bowel Disease in Pregnancy: Results from a Retrospective, Observational StudyUma Mahadevan, Bruce E Sands, Christina Ha, et al.
Therapeutic Advances in Musculoskeletal Disease|April 25, 2022
Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegolMegan Clowse, Rebecca Fischer-Betz, Catherine Nelson-Piercy, et al.
Inflammatory Bowel Diseases|April 3, 2012
Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's diseaseQuy Le, Gil Melmed, Marla Dubinsky, et al.
Diseases of the Colon and Rectum|May 4, 2005
Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammationThomas Hui, Carol Landers, Eric Vasiliauskas, et al.
The American Journal of Gastroenterology|July 12, 2023
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future DirectionsMarla Dubinsky, Alison Potts Bleakman, Remo Panaccione, et al.
Journal of Patient-Reported Outcomes|May 31, 2024
Patient interpretations of patient-reported outcome measures to assess bowel urgency: qualitative interviews in ulcerative colitisVipul Jairath, Theresa Hunter Gibble, Richard Moses, et al.
BMJ Open|April 2, 2022
Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)Konstantinos Papamichael, Vipul Jairath, Guangyong Zou, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Gastro Hep Advances|June 8, 2026
Efficacy of Upadacitinib Retreatment or Dose Escalation After Loss of Response in Ulcerative Colitis: Data From the Open-Label Extension of the U-ACTIVATE StudyRemo Panaccione, Jean-Frédéric Colombel, Marla Dubinsky, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 28, 2008
Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologistsBrennan M R Spiegel, Wayne Ho, Eric Esrailian, et al.
The Lancet. Gastroenterology & Hepatology|November 21, 2025
Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trialJess L Kaplan, Athos Bousvaros, Dan Turner, et al.
Digestive Diseases and Sciences|February 25, 2026
Epidemiology and Treatment of Inflammatory Bowel Disease in Pregnancy: Results from a Retrospective, Observational StudyUma Mahadevan, Bruce E Sands, Christina Ha, et al.
Therapeutic Advances in Musculoskeletal Disease|April 25, 2022
Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegolMegan Clowse, Rebecca Fischer-Betz, Catherine Nelson-Piercy, et al.
Inflammatory Bowel Diseases|April 3, 2012
Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's diseaseQuy Le, Gil Melmed, Marla Dubinsky, et al.
Diseases of the Colon and Rectum|May 4, 2005
Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammationThomas Hui, Carol Landers, Eric Vasiliauskas, et al.
The American Journal of Gastroenterology|July 12, 2023
Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future DirectionsMarla Dubinsky, Alison Potts Bleakman, Remo Panaccione, et al.
Journal of Patient-Reported Outcomes|May 31, 2024
Patient interpretations of patient-reported outcome measures to assess bowel urgency: qualitative interviews in ulcerative colitisVipul Jairath, Theresa Hunter Gibble, Richard Moses, et al.
BMJ Open|April 2, 2022
Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)Konstantinos Papamichael, Vipul Jairath, Guangyong Zou, et al.
Pageof 16